Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an options trading signal again: unusual options activity screeners and strategies. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Sesen Bio Inc (SESN)

Sesen Bio Inc (SESN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Sesen Bio Inc 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 USA

P: 617-444-8550

Description:

Sesen Bio Inc. is a late-stage company developing next-generation antibody-drug conjugate therapies for patients with cancer. The company's product portfolio includes Vicinium(TM) which is in its clinical trial, treats high-grade non-muscle invasive bladder cancer. Sesen Bio Inc., formerly known as Eleven Biotherapeutics, is based in Massachusetts, United States.

Key Statistics

Overview:

Market Capitalization, $K 77,990
Enterprise Value, $K -84,650
Shares Outstanding, K 199,464
Annual Sales, $ 26,540 K
Annual Net Income, $ -340 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -810 K
60-Month Beta 0.62
% of Insider Shareholders 3.20%
% of Institutional Shareholders 14.29%
Float, K 193,081
% Float 96.80%
Short Volume Ratio 0.43

Growth:

1-Year Return -49.15%
3-Year Return -67.95%
5-Year Return -74.28%
5-Year Revenue Growth -11.47%
5-Year Earnings Growth -300.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.05 on 08/08/22
Next Earnings Date 11/14/22
Earnings Per Share ttm -0.07
EPS Growth vs. Prev Year 28.57%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

SESN Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -6.59%
Return-on-Assets % -4.86%
Profit Margin % -1.28
Net Margin % N/A
Debt/Equity 0.00
Price/Sales 2.86
Price/Cash Flow 4.75
Price/Book 0.53
Book Value/Share 0.87
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar